Royal Philips and Banyan Biomarkers have entered into a multiyear agreement to jointly develop and commercialize a handheld blood test for detecting and evaluating mild traumatic brain injury.
Read More
A new three-part differential hematology analyzer delivers lower costs and a wider range of use.
Read MoreEKF has agreed to sell its Selah Genomics subsidiary back to cofounders Michael Bolick and Jeremy Stuart for a “nominal” amount.
Read MoreThe company announced plans to commercialize multiple combination DPP malaria assays to identify Plasmodium falciparum and other Plasmodium infections.
Read MoreCLIA-waived test promises the accuracy of reference laboratory tests for performance at the point of care.
Read More